Sponsor or institution
Clinical trials and research at Osivax Sas
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $1.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A potential universal flu vaccine that targets a stable flu protein (NP)
This project develops a new vaccine meant to protect people from many different flu strains by targeting a stable flu protein called nucleoprotein (NP).
-
Broadly protective flu vaccine that targets a stable viral protein (NP)
A new vaccine that aims to protect people against many different influenza strains by training the immune system to recognize a stable part of the virus called nucleoprotein.
-
Developing a universal vaccine to protect against various strains of influenza
This study is working on a new flu vaccine that could protect against many different strains of the virus, especially during pandemics, by boosting your immune response, and it will be tested in monkeys to see how well it works.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.